Literature DB >> 3779373

The clinical features of mitochondrial myopathy.

R K Petty, A E Harding, J A Morgan-Hughes.   

Abstract

The clinical features of 66 patients with histologically defined mitochondrial myopathy are described. The age of onset of symptoms ranged from birth to 68 years, but was before 20 years in 61%. Nineteen patients had similarly affected relatives. Three groups of cases could be identified clinically: a combination of progressive external ophthalmoplegia and weakness of the limbs induced or increased by exertion (55%); such limb weakness alone (18%); and those with clinical features, such as ataxia, dementia, deafness, involuntary movements and seizures, predominantly or exclusively arising from the CNS (27%). There was considerable overlap between these groups, and pigmentary retinopathy, present in 36% of patients, occurred in all three. At a mean disease duration of twenty years, 9 patients (all from Group 3) were severely disabled but 42 were still able to work. In vitro studies of mitochondrial metabolism, performed in 33 cases, most commonly showed deficiencies of the mitochondrial respiratory chain localized to complex I (18 patients) or complex III (9). No typical clinical picture emerged for any of the identifiable biochemical defects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779373     DOI: 10.1093/brain/109.5.915

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  101 in total

1.  Some physicochemical properties of hemoglobin-manitoba (alpha2 102Ser replaced by Arg (G9) beta2).

Authors:  R N Wrightstone; L L Smith; J B Wilson; F Vella; T H Huisman
Journal:  Biochim Biophys Acta       Date:  1975-12-15

Review 2.  Mitochondria.

Authors:  P F Chinnery; E A Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 3.  Deletions of the mitochondrial genome.

Authors:  A E Harding; S R Hammans
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 4.  Mitochondrial myopathies.

Authors:  S DiMauro; E Bonilla; M Zeviani; S Servidei; D C DeVivo; E A Schon
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Directly repeated sequences associated with pathogenic mitochondrial DNA deletions.

Authors:  D R Johns; S L Rutledge; O C Stine; O Hurko
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Dyssynergia cerebellaris myoclonica (Ramsay Hunt syndrome): a condition unrelated to mitochondrial encephalomyopathies.

Authors:  C A Tassinari; R Michelucci; P Genton; J F Pellissier; J Roger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

7.  Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases.

Authors:  L Bet; M Moggio; G P Comi; C Mariani; A Prelle; N Checcarelli; A Bordoni; N Bresolin; E Scarpini; G Scarlato
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

8.  Vitamin-responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis.

Authors:  H D Bakker; H R Scholte; J A Jeneson; H F Busch; N G Abeling; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

Review 10.  Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification.

Authors:  Gert Van Goethem; Jean-Jacques Martin; Christine Van Broeckhoven
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.